interferon alfacon-1 (Infergen)
interferon alfacon-1 is an FDA-licensed reference biologic from Kadmon Pharmaceuticals LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1997
Reference approved
Reference product
Infergen interferon alfacon-1
Kadmon Pharmaceuticals LLC
- Approved
- Oct 06, 1997
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for interferon alfacon-1, in chronological order.
Reference approval
Approval date of the reference interferon alfacon-1 product.
29 yr 1 mo ago
Frequently asked questions
Are there biosimilars approved for interferon alfacon-1 (Infergen)?
No 351(k) biosimilars or interchangeable biosimilars referencing interferon alfacon-1 are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.